Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schewe

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Deutsche Medizinische Wochenschrift (1946)|February 16, 1979
[Sensitivity of the haemoccult test in colorectal tumours (author's transl)]S Schewe, G Feifel, W Heldwein, et al.
Scandinavian Journal of Rheumatology|May 30, 2013
Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field-strength dedicated extremity magnetic resonance imagingH Strube, C Becker-Gaab, T Saam, et al.
Journal of Neurology|June 25, 2008
Malignant hemispheric infarction in Takayasu arteritisThomas Pfefferkorn, H Bitterling, K Hüfner, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Cardiovascular effects of glucagon before and following propranolol administration]H Lydtin, G Lohmöller, W Daniel, et al.
Bildgebung = Imaging|January 1, 1991
[Indications for sonography and follow-up studies. Initial results of a prospective study]W G Zoller, U Gresser, G Brenner, et al.
Zeitschrift Fur Rheumatologie|July 16, 2010
[Quality of a multidisciplinary orthopaedic-rheumatological consultation]S Mayer-Wagner, F Wiendl, S Schewe, et al.
Annals of the Rheumatic Diseases|October 31, 2007
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of responseJ Braun, X Baraliakos, J Listing, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Deutsche Medizinische Wochenschrift (1946)|February 16, 1979
[Sensitivity of the haemoccult test in colorectal tumours (author's transl)]S Schewe, G Feifel, W Heldwein, et al.
Scandinavian Journal of Rheumatology|May 30, 2013
Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field-strength dedicated extremity magnetic resonance imagingH Strube, C Becker-Gaab, T Saam, et al.
Journal of Neurology|June 25, 2008
Malignant hemispheric infarction in Takayasu arteritisThomas Pfefferkorn, H Bitterling, K Hüfner, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Cardiovascular effects of glucagon before and following propranolol administration]H Lydtin, G Lohmöller, W Daniel, et al.
Bildgebung = Imaging|January 1, 1991
[Indications for sonography and follow-up studies. Initial results of a prospective study]W G Zoller, U Gresser, G Brenner, et al.
Zeitschrift Fur Rheumatologie|July 16, 2010
[Quality of a multidisciplinary orthopaedic-rheumatological consultation]S Mayer-Wagner, F Wiendl, S Schewe, et al.
Annals of the Rheumatic Diseases|October 31, 2007
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of responseJ Braun, X Baraliakos, J Listing, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Pageof 3